According to GEPIA, iPLA2β/PLA2G6 expression is downregulated in 15 tumor types (Table 3) [9], whereas iPLA2δ/PNPLA6 expression is only downregulated in three types. This evidence concerns the gene PLA2G6 and neoplasm.